Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serlopitant for pruritus in prurigo nodularis
NCT03677401Phase 3Completed
- Sponsor
- Vyne Therapeutics
- Start
- Aug 2018
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of serlopitant in prurigo nodularis (PN), sponsored by Vyne Therapeutics. Started Aug 2018; status: completed.
02
Drugs
serlopitant
03
Conditions
prurigo nodularis (PN)
Beyond the preview
Go deeper on NCT03677401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03677401.